Aytu Biopharma (AYTU) Interest Expenses (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Interest Expenses of $20.7 million for Q1 2026, up 315.03% year-over-year from $5.0 million in Q1 2025, and little changed quarter-over-quarter from $20.7 million in Q4 2025.
Aytu Biopharma (AYTU) Interest Expenses (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Interest Expenses for 17 consecutive years, with $20.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 315.03% year-over-year to $20.7 million; the TTM figure through Mar 2026 stood at $20.7 million (up 315.03% YoY), while the FY2025 annual figure was $136.6 million, changed 0.47% from the prior year.
- Interest Expenses held at $20.7 million in Q1 2026 per AYTU's latest filing, from $20.7 million in the prior quarter.
- Across five years, Interest Expenses topped out at $194.3 million in Q1 2023 and bottomed at -$466.2 million in Q2 2023.
- Historically, Interest Expenses has averaged -$1.4 million across 5 years, with a median of $20.7 million in 2026.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 422.03% — and 2023, when it plunged 685688.24%.
- Aytu Biopharma's Interest Expenses stood at $33.0 million in 2022, then sank by 84.91% to $5.0 million in 2023, then jumped by 394.39% to $24.7 million in 2024, then dropped by 16.03% to $20.7 million in 2025, then fell by 0.0% to $20.7 million in 2026.
- Business Quant data shows AYTU's Interest Expenses at $20.7 million in Q1 2026, $20.7 million in Q4 2025, and $20.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Aytu Biopharma | 24.81 Mn | -1.91 Mn | 7.60 Mn | 436,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.71 Mn |
| Mar 31, 2026 | 20.71 Mn |
| Dec 31, 2025 | 20.71 Mn |
| Dec 31, 2025 | 20.71 Mn |
| Sep 30, 2025 | 20.71 Mn |
| Sep 30, 2025 | 20.71 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Dec 31, 2024 | 24.66 Mn |
| Dec 31, 2024 | 24.66 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Sep 30, 2024 | 4.99 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Mar 31, 2024 | 4.99 Mn |
| Dec 31, 2023 | 4.99 Mn |
| Dec 31, 2023 | 4.99 Mn |